The 20 Best Prostate Cancer Doctors Near Me in Reston, VA

Dr. Inger Rosner is a board-certified urologic oncologist. She joined Inova Health System in 2020 and has been practicing urologic oncology since 2007. Prior to joining Inova, Dr. Rosner was the Director of the Urologic Oncology Service at Walter Reed National Military Medical Center. Additionally, she was the Director of the Center for Prostate Disease Research at Uniformed Services University of the Health Sciences. Dr. Rosner was the Principal Investigator for several research protocols and clinical trials and has published dozens of papers based on her research in the field of urology oncology. She is interested in patient health care disparities and quality of life outcomes in patients diagnosed with and treated for prostate cancer along their continuum of cancer care. Additionally, her clinical interests include multi-disciplinary care of urologic cancer patients from the newly diagnosed to the advanced stages of disease. She specializes in minimally-invasive and robotic-assisted surgery. Dr. Rosner received her Doctor of Medicine from Uniformed Services University and completed her surgical residency in urology at Walter Reed Army Medical Center. She did her fellowship training in urologic oncology at the National Cancer Institute. Dr. Rosner served 23 years on active duty service in the United States Army and retired as Colonel. Dr. Rosner is married to Dr. Michael Rosner, a neurosurgeon at George Washington University Hospital in Washington, DC. They have three sons and live in Bethesda, MD. Dr. Rosner is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, Prostatectomy, and Nephrectomy.

Wohlscheid Director, Genitourinary Oncology Research Inova Schar Cancer Dr. Jeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as Associate Professor of Medical Education at the University of Virginia. Dr. Aragon-Ching joined Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Program Planning Committee from 2017-2019, served as Track Chair for Urothelial cancers in 2018 and Renal Cell Cancer Track in 2016–2017 and member of the Prostate cancer track. She has chaired different sessions on bladder urothelial and non-urothelial cancers, kidney and prostate cancers. She also served in the ASCO Cancer Education Committee for the annual meeting for the GU non-prostate cancers. She is dedicated to the research and clinical care of patients with genitourinary cancers. Dr. Aragon-Ching completed her internship and residency at the Albert Einstein Medical Center in Philadelphia, PA, where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, MD, where she served as an Associate Investigator on varying trials involved with pharmacogenomics and early drug discovery for genitourinary tumors. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, circulating tumor cells, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. She is a well-published author and investigator of multiple GU trials, including prostate cancer, bladder cancer and kidney cancer trials. She is a well-established educator and serves on the editorial board of various academic journals. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology, Best of ASCO, AUA, EAU, and the ASCO Annual meeting. She has also been previously named a “Top Doctor” by Washingtonian magazine and a “Best Doctor” by the Northern Virginia magazine. Dr. Aragon is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Paller is board certified in American Board Of Internal Medicine.

Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Myxoid Liposarcoma, Liposarcoma, and Prostatectomy. Dr. Deville is board certified in American Board Of Radiology.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

. Dr. Khetpal is rated as an Experienced provider by MediFind in the treatment of Prostate Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Khetpal is board certified in American Board Of Internal Medicine.

Peter Pinto is a Urologist practicing medicine in Bethesda, Maryland. Dr. Pinto is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Enlarged Prostate (BPH), Prostatectomy, and Nephrectomy.

Ravi Madan is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Madan is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Chordoma, Medullary Thyroid Carcinoma, Orchiectomy, and Prostatectomy.

William Dahut is an Oncologist practicing medicine in Bethesda, Maryland. Dr. Dahut is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Bone Tumor, Prostatectomy, and Orchiectomy.

James Gulley is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Gulley is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Olfactory Neuroblastoma, Chordoma, Urothelial Cancer, and Orchiectomy.

Nicholas Lailas is a Urologist practicing medicine in Reston, Virginia. Dr. Lailas is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Reconstructive Urology Surgery.

Dr. Joshua Allen is a specialty care physician board certified in hematology, medical oncology and internal medicine. He joined Inova in 2020 and has been practicing since 2017. A native of Utah, Dr. Allen resides in Northern Virginia with his wife and children. Outside of work, he enjoys music (piano and violin), the outdoors and traveling. Dr. Allen is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Thrombocytopenia, and Wilms Tumor.

Dr. Brian DeCastro is a specialty care physician board certified in urology. He joined Inova in 2023 and has been practicing since 2003. Prior to joining Inova, Dr. DeCastro worked as a urologist at Fauquier Health Urology, Fauquier Hospital in Warrenton, VA. Dr. DeCastro grew up near Syracuse, NY. After earning his medical degree from Upstate Medical University in 2002, he completed his urologic training at Madigan Army Medical Center in Tacoma, WA. Dr. DeCastro practiced as an Army urologist at Winn Army Community Hospital in Fort Stewart, GA, until he was honorably discharged in 2013 after 11 years of service. Since then, he has been practicing in Northern Virginia. Dr. DeCastro believes that the patient always comes first and thrives on helping others. His clinical areas of interest include kidney stones, benign prostatic hyperplasia, low testosterone, erectile dysfunction, bladder cancer, elevated PSA, prostate cancer, and aquablation specialist. He has been featured in Northern Virginia Magazine’s Top Docs. Dr. Decastro is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Ureteroscopy, and Nephrectomy.

John Ruff is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Ruff is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Pulmonary Fibrosis, Visceromegaly, and Bone Marrow Aspiration.

Dr. Simon Chung is a specialty care physician board certified in urology at Inova Health System. Dr. Chung joined Inova in 2014 and has been practicing since 1993. He served as an active medical staff member at Inova Fairfax Hospital and served as the hospital’s Urology Section Chief until 2022. Prior to joining Inova, Dr. Chung was the Rotation Site Director for George Washington University’s urology residency program from 1993 to 2013 and was honored four times by the residents with an Excellence in Teaching Award. He has been named to “Top Doctor” lists in several regional publications since entering his practice and earned national recognition on the Castle Connolly Top Doctors list. Dr. Chung’s clinical areas of interest include urological cancers, stone disease, and minimally invasive and robotic surgeries. He was among the first surgeons worldwide, in 2004, to perform robotic-assisted laparoscopic surgery and has accumulated a varied and extensive experience to safely treat cancers, anatomic abnormalities and traumatic injuries of the urinary system. He has devised kidney-sparing cancer surgery (robotic-assisted laparoscopic partial nephrectomy) strategies for complex kidney tumor removal that otherwise would result in unnecessary loss of the entire kidney. Dr. Chung has assisted in the development and growth of robotic surgery programs in gynecology, colorectal surgery, general surgery, otorhinolaryngology, pediatric surgery and transplant surgery at Inova. In consideration of these efforts, Dr. Chung was designated System Medical Director of Robotics for Inova in 2022. Dr. Chung is proud of his patient-centric approach to healthcare delivery, emphasizing patient education with plain language discussions and shared decision making. The “Golden Rule” (do unto others…) applies to his patient care philosophy. Outside his medical world, Dr. Chung spends as much time with his family and close friends as possible. He is a lifelong builder of radio-controlled model aircraft and model rockets. Someday, he’ll get them off the ground again. Dr. Chung is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Prostate Cancer, Vasectomy, and Reconstructive Urology Surgery.

Dr. Kevin Choe is a specialty care physician board certified in radiation oncology at Inova Health System. He joined Inova in 2015 and has been practicing since 2005. Prior to joining Inova, Dr. Choe was on the faculty at University of Texas, Southwestern Medical Center in Dallas, TX, where he specialized in high-precision stereotactic radiotherapy. His research focused on elucidating the genetic alterations that contribute to cancer development and progression. He also designed and conducted clinical trials, investigating novel strategies to overcome treatment resistance in aggressive and metastatic cancers. Dr. Choe grew up in Fairfax, VA, and appreciates the opportunity to serve the community he cares deeply for. Dr. Choe is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Metastatic Brain Tumor, and Posterior Fossa Tumor.

Dr. Daniel Kim is a specialty care physician board certified in radiation oncology at Inova Health System. Dr. Kim graduated top of his class from Amherst College with degrees in neuroscience and music, while becoming a four-time All-American tennis athlete and winning the NCAA men’s tennis championship. He graduated with his MD and MBA, with honors, from Harvard. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, Meningioma, and Prostatectomy.

Dr. Edmond Paquette is a specialty care physician board certified in urology at Inova. He joined Inova in 2017. Before joining Inova, Dr. Paquette practiced at Dominion Urology in Fairfax, VA. Dr. Paquette graduated from the University of Rhode Island in South Kingstown, majoring in zoology and graduating with honors, then obtained his medical degree from Brown University School of Medicine in Providence, RI. He completed a surgical internship at Madigan Army Medical Center in Fort Lewis, WA, followed by two years of service as a general medical officer with the United States Army in Germany and Bosnia. Upon his return, Dr. Paquette completed his residency in urology at Walter Reed Army Medical Center, where he also spent one year as a research fellow studying the epidemiology and treatment of prostate cancer. Following residency, Dr. Paquette became Chief of Urology and Interim Chief of Surgery at Womack Army Medical Center in Fort Bragg, NC. While in the military, Dr. Paquette served with the 10th Combat Support Hospital in Baghdad during Operation Iraqi Freedom. He was honorably discharged after 13 years of service as a lieutenant colonel, having received the Meritorious Service Medal twice, the NATO Medal, the Overseas Ribbon and the War on Terrorism Medal. Dr. Paquette has authored nearly two dozen peer-reviewed scholarly articles. His primary interests include the treatment of benign prostate hyperplasia, kidney stones, reconstructive urology, prosthetics, male incontinence, erectile dysfunction, vasectomy reversal and prostate cancer. He is currently an Associate Professor of Surgery at the University of Virginia School of Medicine and is the Co-Clerkship Director for the University of Virginia School of Medicine’s urology rotation on the Inova campus. Dr. Paquette is certified by the American Board of Urology and is a fellow of the American College of Surgeons. Outside the office, Dr. Paquette enjoys coaching his five children in basketball and soccer. Dr. Paquette is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

Dr. Michael J. Eblan is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2016. Prior to joining Radiation Oncology Associates, he completed his internal medicine internship and radiation oncology residency at the University of North Carolina at Chapel Hill. There, he served as chief resident, led quality and safety initiatives to improve patient care, and designed prospective clinical investigations of circulating tumor cells as a novel biomarker for radiation treatment response. During his residency, Dr. Eblan also completed additional training in CyberKnife robotic radiosurgery and earned a Lean Six Sigma Yellow Belt certification. Much of his research has focused on the effects of radiation on normal tissues and the development of nanotherapeutics to improve the efficacy of chemoradiotherapy and immunotherapy at the Carolina Center of Cancer Nanotechnology Excellence. Dr. Eblan is trained in all aspects of radiation oncology and has particular clinical interest in thoracic, gastrointestinal, breast, prostate, brain, head and neck, hematologic, and pediatric malignancies. He is experienced with multiple radiotherapy techniques, including proton beam therapy, volumetric modulated arc therapies, intensity-modulated radiation therapy, stereotactic body radiotherapy, CyberKnife radiosurgery, intraoperative radiotherapy, and prostate and gynecologic brachytherapy, including high-dose-rate brachytherapy. His work has been recognized by the American Society for Radiation Oncology, the American Association for Cancer Research, the Conquer Cancer Foundation and the American Society of Clinical Oncology. Dr. Eblan grew up in Fairfax County and graduated with distinction as an Echols Scholar from the University of Virginia, receiving dual degrees in biology and economics. He then trained at the National Institutes of Health in Bethesda, MD, through a postbaccalaureate Intramural Research Training Award and published numerous research articles on genetic alterations contributing to human disease, including publication in the New England Journal of Medicine. He received his medical degree from the University of Pennsylvania School of Medicine, where he was awarded the Ruth L. Kirschstein National Research Service Award to study cancer biology and proton radiotherapy. Dr. Eblan is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Prostate Cancer, and Familial Prostate Cancer.

Brett Holt is a Urologist practicing medicine in Fairfax, Virginia. Dr. Holt is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Reconstructive Urology Surgery.